Clinical manifestations in two patients with pyruvate dehydrogenase deficiency and long-Term survival

7Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Pyruvate dehydrogenase E1-Alpha deficiency (PDHAD) results in lactic acidosis and hyperpyruvatemia. Two patients with PDHAD, a man with a p.R263Q mutation, and a girl with a p.C145del mutation in PDHE1α, presented with lactic acidosis with neurological disorder. These patients were able to survive for a long period under careful nursing care. Herein, we discuss the factors contributing to their relatively stable clinical course, albeit with intellectual disability.

Cite

CITATION STYLE

APA

Yoshida, T., Kido, J., Mitsubuchi, H., Matsumoto, S., Endo, F., & Nakamura, K. (2017). Clinical manifestations in two patients with pyruvate dehydrogenase deficiency and long-Term survival. Human Genome Variation, 4. https://doi.org/10.1038/hgv.2017.20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free